Navigation Links
Innovative Clinical Solutions, Ltd. Announces Second and Final Liquidating Cash Distribution

PHILADELPHIA, Dec. 13, 2010 /PRNewswire-FirstCall/ -- Innovative Clinical Solutions, Ltd. (Pink Sheets: ICSN) has announced that, in accordance with its plan of liquidation approved by its shareholders on September 22, 2007, its sole Director has approved a second and final liquidating cash distribution (the "Final Liquidating Distribution") in the amount of $0.039251 per share of its outstanding common stock.  The Final Liquidating Distribution will have a record date of December 9, 2010, a payment date of December 16, 2010, and an ex-dividend date of December 17, 2010.  The stock transfer books of the Company will be closed as of December 16, 2010.  The Company will make no further distributions beyond the Final Liquidating Distribution.  There is no requirement for stockholders to surrender shares in connection with the Final Liquidating Distribution.  

An "ex-dividend date" is the date on which a security is traded without a previously declared dividend or distribution.  The timing of the Company's ex-dividend date is determined in accordance with the FINRA rule applicable to such distributions, because the amount of the distribution exceeds 25% of the Company's share value.  Between the record date of December 9, 2010, and the ex-dividend date of December 17, 2010, the stock will trade with due bills reflecting the seller's obligation to transfer the distribution to the buyer.  The due bill redeemable date is December 21, 2010.  

Upon payment of the Final Liquidating Distribution, the Company will have made liquidating distributions (including the first partial liquidating cash distribution made on June 30, 2008, and the Final Liquidating Distribution) in the aggregate amount of $2,990,755, or $0.249251 per share of the Company's common stock.  

Safe Harbor

This press release may contain forward-looking statements within the meaning of the federal securities laws, including statements regarding the timing and amounts available for distributions to holders of the Company's common stock.  Such statements reflect the Company's current expectations with respect to future events and are based on its current assumptions and information currently available.  Actual results may differ materially.  There can be no assurance that the Company's expectations will be achieved.  These forward looking statements are neither promises nor guarantees.  The Company undertakes no responsibility to revise or update and such forward-looking statements.  

SOURCE Innovative Clinical Solutions, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ActiveHealth Management to Deliver Innovative NuVal™ Nutritional Scoring System Through Health Website
2. Chilean Companies Show Innovative Solutions
3. Top Business School Students From Around the World Compete for Innovative Solutions to the Global Clean Water Crisis
4. FDA Launches Initiative to Develop Innovative External Defibrillators
5. Argos Therapeutics to Present Potential of its Arcelis™ Immunotherapy as an Innovative, Effective Treatment for HIV at the APHA 138th Annual Meeting & Exposition
6. NxStage® Expands Product Portfolio With Innovative Patient Access Surveillance Solution From Vasc-Alert™
7. New England Biolabs Launches a Suite of Innovative Tools to Advance Epigenetics Research, Including PCR-Based Assay to Identify and Quantitate 5-hmC in Epigenome
8. CVS Caremark Research Highlights How Innovative Plan Designs Help Clients Reduce Drug Spend and Improve Generic Dispensing Rates
9. Physicians Pharmaceutical Corporation Offers Innovative On-Site Drug Dispensaries
10. Results of Innovative Clinical Study Show New Combination for Weight Loss Success
11. AT&T and eCardio Diagnostics Team Up to Advance Cardiac Care Through Innovative Mobile Technology
Post Your Comments:
(Date:11/25/2015)... Calif. , Nov. 25, 2015  Amgen (NASDAQ: ... Biologics License Application (BLA) with the United ... for ABP 501, a biosimilar candidate to Humira ® ... adalimumab biosimilar application submitted to the FDA and represents ... Sean E. Harper , M.D., executive vice ...
(Date:11/25/2015)... , Nov. 25, 2015 AAIPharma ... planned investment of at least $15.8  Million to ... Wilmington, NC . The expansion will ... to meet the growing demands of the pharmaceutical ... site expansion will provide up to 40,000 ...
(Date:11/25/2015)... Nov. 25, 2015  Henry Schein, Inc., the world,s ... office-based dental, medical and animal health practitioners, will unveil ... Henry Schein ConnectDental® Pavilion , which brings together ... open solutions designed to help any practice or laboratory ... for a schedule of experts appearing at the ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... Jobs in hospital medical ... professionals and offered by healthcare staffing agency Aureus Medical Group . ... of October 2015 among those searching for healthcare jobs through the company’s website, ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., the first ... annual Employee Benefits Conference. The Employee Benefits Conference was hosted by the International ... November 11th, 2015. The conference was held at the Hawaii Convention Center in ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... and wellness consultation, has collaborated with Women’s Web – an online resource ... on topics on mental and emotional well-being relationship, life balance, stress, professional ...
(Date:11/25/2015)... ... November 25, 2015 , ... Additional breast cancers found with ... according to a study published online in the journal Radiology. Researchers said that ... necessitate a change in treatment. , Breast MRI is the most sensitive technique ...
(Date:11/25/2015)... ... November 25, 2015 , ... The holiday ... dish and pleasing the palates of attendees is of the utmost importance. Whether ... a seasonal get-together, give these recipes a try this holiday season. , Turkey ...
Breaking Medicine News(10 mins):